Exploring the dynamics of respiratory syncytial virus (RSV) transmission in children

Alexandra B Hogan1, Kathryn Glass1, Hannah C Moore2

  • 1National Centre for Epidemiology and Population Health, Building 62, Corner Mills and Eggleston Roads, The Australian National University, Canberra ACT 2601, Australia.

Insights

This study models respiratory syncytial virus (RSV) dynamics, revealing how birth rates, transmission, and seasonality influence annual and biennial epidemic cycles. Findings explain regional variations in RSV outbreaks and inform public health strategies.

Area of Science:

  • Epidemiology
  • Mathematical Biology
  • Virology

Background:

  • Respiratory syncytial virus (RSV) is a primary cause of pediatric lower respiratory tract infections.
  • RSV exhibits distinct seasonal patterns, including annual, biennial, and delayed biennial cycles.
  • Understanding these dynamics is crucial for public health interventions.

Purpose of the Study:

  • To develop and analyze a mathematical model of RSV infection dynamics.
  • To identify parameter ranges that generate observed annual, biennial, and delayed biennial RSV patterns.
  • To elucidate the drivers of RSV seasonality and transmission.

Main Methods:

  • Development of a compartmental model for RSV infection.
  • Incorporation of a seasonal forcing function to simulate transmission.
  • Conducting parameter space and bifurcation analyses to explore model behavior.

Main Results:

  • The model replicates diverse RSV dynamics, sensitive to birth rate, transmission, and seasonality parameters.
  • Biennial cycles emerge when the seasonality parameter exceeds a threshold.
  • Intermediate birth rates delay biennial cycles; short immunity duration leads to annual cycles.

Conclusions:

  • The model's dynamics align with observed RSV outbreak regularity, including biennial patterns in Western Australia and delayed biennial patterns in Finland.
  • Key factors influencing RSV seasonality include birth rate, transmission efficiency, and duration of immunity.
  • Findings offer insights into RSV transmission drivers and a basis for intervention strategies.

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.7K
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
1
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.8K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.9K